Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal
Recruiting
N/A
Interventional Study
Hypertension (HTN)
Diabetes (DM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 398 (estimated)
- Sponsor
- Kathmandu University School of Medical Sciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hypertension (HTN) and diabetes mellitus are significant global public health challenges, contributing to 13.5% of premature deaths, 54% of incident strokes, and 47% of coronary heart disease cases (HTN), and increasing risks of cardiovascular diseases, kidney failure, and other complications (diabetes). In Nepal, HTN prevalence is 24.5% and diabetes affects 5.8% of adults (2019 Nepal STEPS Survey…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 30 years or older
* have a high blood pressure of 140/90 mmHg or under hypertension medication
* have a high blood sugar of 6.5% or more (hba1c) or under diabetes medication are able to provide informed consent
Exclusion Criteria:
* any form of disabilities limiting particip…
Contacts